Q Fever Workup

  • Author: Kelley Struble, DO; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Jan 25, 2012
 

Approach Considerations

The diagnosis of Q fever relies on a high index of suspicion as suggested by the epidemiologic features and is proven by serologic analysis. The organism is very infectious, and isolation ought to be done in biosafety level 3 laboratories.[20] If a clinician thinks Q fever is a likely diagnosis, the laboratory should be notified so that they can take appropriate precautions.

Electrocardiography (ECG) may show T-wave abnormalities if myocarditis and pericarditis are present.

Next

Routine Laboratory Studies

Acute Q fever may present with the following laboratory results:

  • A complete blood cell (CBC) count usually shows a normal white blood cell (WBC) count (70-90%) (elevated WBC in as many as 30%.), mild thrombocytopenia (25%) (followed by a reactive thrombocytosis during the convalescent period[9] ), and, in rare cases, hemolytic anemia
  • Liver function tests usually show mild elevation of transaminases (2-3 times the reference range in 70-85% of patient) and alkaline phosphatase (2-3 times the reference range) without hyperbilirubinemia
  • The erythrocyte sedimentation rate (ESR) is usually elevated (55 mm/h ± 30 mm/h)
  • Several positive autoimmune antibodies, including antismooth muscle and antiphospholipid, may be seen
  • Blood cultures are typically negative (Note that, although possible, attempting to isolate the organism from blood is a dangerous practice; cases of Q fever have developed in laboratory technicians)

C burnetii can be seen on smears or frozen tissue prepared with a routine Giemsa stain. Histopathologic changes consistent with doughnut granulomata the liver and bone marrow may be observed, but these are not specific for C burnetii. They can also occur in Hodgkin lymphoma, typhoid fever, cytomegalovirus infection, infectious mononucleosis, and allopurinol hypersensitivity.

In chronic Q fever, the following laboratory results may be observed:

  • Anemia of chronic disease
  • Elevated ESR
  • Elevated gamma globulins (polyclonal)
  • Elevated rheumatoid factor (RF)
  • Increased creatinine levels
Previous
Next

Serology

Most cases of Q fever are diagnosed based on detection of phase I and II antibodies (between acute and convalescent paired sera); a 4-fold rise in complement-fixing antibody titer against phase II antigen occurs and yields the highest specificity. This requires a baseline sample and another sample in 3-4 weeks. Thus, serologic tests are not helpful acutely but may later confirm the diagnosis: Seroconversion generally occurs between days 7 and 15 and is almost always present by 21 days.

The 3 serologic techniques used for diagnosis include indirect immunofluorescence (IIF) (method of choice), complement fixation, and enzyme-linked immunosorbent assay (ELISA) (comparable to IIF). As noted above, significant titers may take 2-4 weeks to appear. Laboratory values vary considerably, so clinicians must interpret results according to their local standards.

Raoult et al recommended serologic testing 2 years following treatment in patients with valvulopathy after acute infection,[21] whereas Healy et al recommended serial testing every 4 months for 2 years, with additional investigation in those with elevated phase 1 immunoglobulin G (IgG) titers greater than 800.[22]

Serologic follow-up to detect a rise in phase I IgG titers of 1:800 or more can be performed twice every 3 months. If detected, transesophageal echocardiography and serum real-time polymerase chain reaction (PCR) techniques can be performed in an attempt to diagnose endocarditis.[12, 23] Sensitivities may be as low as 18% in early disease.

Interpretation of Q fever serology is challenging in regard to discordance of the serologic results from different reference laboratories.[24] None of these results should be used in isolation, and their interpretation should always be applied in the appropriate clinical context. False-positive serologic results may occur in legionellosis and leptospirosis.

Indirect immunofluorescence assay

IIF findings in acute Q fever include the following:

  • A rise in IgG and IgM against phase II antigen[6]
  • Phase II IgM of 1:50 or more; usually undetectable after 4 months but can last 12 months or more
  • Phase II IgG of 1:200 or more
  • Phase II titers of 1:100 or less make the diagnosis of acute Q fever unlikely
  • In a reference French laboratory, these values showed 100% specificity

IIF findings in chronic Q fever include the following:

  • A rise in IgG and IgA against phase I antigen[6]
  • Phase I IgG of 1:800 or more is considered diagnostic of endocarditis (one of major modified Duke criteria)
  • Phase II IgM titers are lower or absent
  • Phase II IgG titers are usually greater than 1:1600; they can last up to 12 years after an outbreak
  • The main predictive criterion of clinical cure is detection of phase I IgG titer of less than 1:200

Complement fixation

Complement fixation is less sensitive and specific than IIF, and the time to positivity may take longer than IIF. Different cutoff values are also used. IgG levels usually fall within 3 years.

In acute Q fever, the anti-IgG titer is at least 200, and the anti- IgM titer level is at least 50. In chronic Q fever, the anti-IgA titer for phase I is greater than 50, and the anti-IgG titer for phase I is greater than 800.

Previous
Next

Polymerase Chain Reaction

In certain reference laboratories, polymerase chain reaction (PCR) techniques can be used with tissue specimens, such as resected cardiac valves, with greater sensitivity than serum assays, but these are not generally available commercially. C burnetii organisms can persist in tissues even after prolonged antimicrobial treatment.[15] Although still controversial, serum PCR may be used to diagnose acute Q fever in the first 2 weeks of the disease. It should also be reserved for seronegative patients in the subsequent 2 weeks and not used later than 4 weeks following onset.[23]

Previous
Next

Radiologic Studies

In the rare patient with prominent neurologic symptoms, computed tomography (CT) scanning of the brain may be indicated; otherwise, a chest radiograph is the only imaging study that is likely to be useful. An atypical pneumonia pattern may be observed, similar to the pattern seen with pneumonia caused by viruses and Mycoplasma, Chlamydia, and Legionella species. Opacities more specific to Q fever resemble a coin lesion.[9]

In acute Q fever, chest radiographic findings are variable. Nonspecific segmental or lobar abnormalities may be seen (see the following image), such as opacities of both lungs, most consistent with an atypical pneumonia. Multiple round opacities and pleural effusions are the hallmark of Q fever pneumonia, but they are uncommon. In chronic illness, signs of interstitial fibrosis and pseudotumor may be observed.

A: Chest radiograph with normal findings. B: ChestA: Chest radiograph with normal findings. B: Chest radiograph demonstrating Q fever pneumonia.
Previous
Next

Hepatic and Cardiac Ultrasonography

Ultrasonography, primarily of the liver, is indicated because chronic hepatomegaly is frequently associated with endocarditis. Granulomatous hepatitis, even in asymptomatic patients, may be revealed.[9]

Echocardiography is recommended to exclude underlying cardiac lesions. About 30-50% of patients with valvular lesions develop chronic endocarditis (most commonly, aortic valve; prosthetic valves are also prone to being affected). In cases of Q fever endocarditis, the cardiac echocardiogram demonstrates vegetations in only 12% of cases. These vegetations tend to be smaller than observed with other organisms and are located beneath endothelial surfaces.[15] Other findings include valvular abscesses, valvular regurgitation, and prosthetic valve dehiscence. Pericardial effusion may also be seen with pericarditis in Q fever.

Previous
 
 
Contributor Information and Disclosures
Author

Kelley Struble, DO  Fellow, Department of Infectious Diseases, University of Oklahoma College of Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Alexandre Lacasse, MD, MSc  Internal Medicine Faculty, Assistant Director, Medicine Clinic, Infectious Disease Consultant, St Mary's Health Center

Alexandre Lacasse, MD, MSc is a member of the following medical societies: American College of Physicians, American Medical Association, Association of Program Directors in Internal Medicine, Infectious Diseases Society of America, and Society for Healthcare Epidemiology of America

Disclosure: Nothing to disclose.

Kerry O Cleveland, MD  Associate Professor of Medicine, University of Tennessee College of Medicine; Consulting Staff, Department of Internal Medicine, Division of Infectious Diseases, Methodist Healthcare of Memphis

Kerry O Cleveland, MD is a member of the following medical societies: American College of Physicians, Infectious Diseases Society of America, and Society for Healthcare Epidemiology of America

Disclosure: Nothing to disclose.

Hari Polenakovik, MD  Associate Professor of Medicine, Wright State University, Boonshoft School of Medicine

Hari Polenakovik, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Society for Microbiology, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, and Society for Healthcare Epidemiology of America

Disclosure: Nothing to disclose.

Annie Ruest, MD, FRCPC  Consultant Physician in Infectious Diseases and Medical Microbiology, CHUQ-Hôtel-Dieu de Québec, Departments of Medicine and Medical Biology, Laval University Faculty of Medicine, Canada

Annie Ruest, MD, FRCPC is a member of the following medical societies: Canadian Infectious Disease Society and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Christian P Sinave, MD  Associate Professor, Department of Medical Microbiology and Infectious Diseases, University of Sherbrooke Faculty of Medicine, Canada

Christian P Sinave, MD is a member of the following medical societies: American Society for Microbiology and Canadian Infectious Disease Society

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Additional Contributors

Leslie L Barton, MD Professor Emerita of Pediatrics, University of Arizona College of Medicine

Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Dan Danzl, MD Chair, Department of Emergency Medicine, Professor, University of Louisville Hospital

Dan Danzl, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Kentucky Medical Association, Society for Academic Emergency Medicine, and Wilderness Medical Society

Disclosure: Nothing to disclose.

Robert G Darling, MD, FACEP Clinical Assistant Professor of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, F Edward Hebert School of Medicine; Associate Director, Center for Disaster and Humanitarian Assistance Medicine

Robert G Darling, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, and Association of Military Surgeons of the US

Disclosure: Nothing to disclose.

Vinod K Dhawan, MD, FACP, FRCP(C) Professor, Department of Clinical Medicine, University of California, Los Angeles, David Geffen School of Medicine; Chief, Division of Infectious Diseases, Rancho Los Amigos National Rehabilitation Center, Downey, California.

Vinod K Dhawan, MD, FACP, FRCP(C) is a member of the following medical societies: American College of Physicians, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, and Royal College of Physicians and Surgeons of Canada

Disclosure: Pfizer Inc Honoraria Speaking and teaching

Jonathan A Edlow, MD Associate Professor of Medicine, Department of Emergency Medicine, Harvard Medical School; Vice Chairman, Department of Emergency Medicine, Beth Israel Deaconess Medical Center

Jonathan A Edlow, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Jon Mark Hirshon, MD, MPH Associate Professor, Department of Emergency Medicine, University of Maryland School of Medicine

Jon Mark Hirshon, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Public Health Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Joseph F John Jr, MD, FACP, FIDSA, FSHEA Clinical Professor of Medicine, Molecular Genetics and Microbiology, Medical University of South Carolina College of Medicine; Associate Chief of Staff for Education, Ralph H Johnson Veterans Affairs Medical Center

Disclosure: Nothing to disclose.

Rick Kulkarni, MD Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

John M Leedom, MD Professor Emeritus of Medicine, Keck School of Medicine of the University of Southern California

John M Leedom, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, American Society for Microbiology, Infectious Diseases Society of America, International AIDS Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Geofrey Nochimson, MD Consulting Staff, Department of Emergency Medicine, Sentara Careplex Hospital

Geofrey Nochimson, MD is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Robert L Norris, MD Associate Professor, Department of Surgery; Chief, Division of Emergency Medicine, Stanford University Medical Center

Robert L Norris, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, California Medical Association, International Society of Toxinology, Society for Academic Emergency Medicine, and Wilderness Medical Society

Disclosure: Nothing to disclose.

Miller B Pearsall, MD Resident Physician and Clinical Assistant Instructor, Department of Emergency Medicine, State University of New York Downstate School of Medicine, Kings County Hospital Center, University Hospital of Brooklyn

Miller B Pearsall, MD is a member of the following medical societies: American College of Emergency Physicians and Emergency Medicine Residents Association

Disclosure: Nothing to disclose.

José Rafael Romero, MD Director of Pediatric Infectious Diseases Fellowship Program, Associate Professor, Department of Pediatrics, Combined Division of Pediatric Infectious Diseases, Creighton University/University of Nebraska Medical Center

José Rafael Romero, MD is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, New York Academy of Sciences, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Richard H Sinert, DO Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center

Richard H Sinert, DO is a member of the following medical societies: American College of Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Russell W Steele, MD Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Jeter (Jay) Pritchard Taylor III, MD Compliance Officer, Attending Physician Emergency Medicine Residency, Department of Emergency Medicine, Palmetto Richland Memorial Hospital, University of South Carolina

Jeter (Jay) Pritchard Taylor III, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

References
  1. Centers for Disease Control and Prevention. Emergency preparedness and response: bioterrorism agents/diseases. Available at http://www.bt.cdc.gov/agent/agentlist-category.asp. Accessed October 6, 2011.

  2. Marrie TJ, Raoult D. Coxiella burnetii (Q fever). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, Pa: Churchill Livingstone; 2005:2296-303.

  3. Samuel JE, Hendrix LR. Laboratory maintenance of Coxiella burnetii. Curr Protoc Microbiol. Nov 2009;Chapter 6:Unit 6C.1. [Medline].

  4. Raoult D, Stein A. Q fever during pregnancy: a risk for the mother, for the fetus and for the obstetrician. N Engl J Med. 1994;330:371.

  5. Ong C, Ahmad O, Senanayake S, Buirski G, Lueck C. Optic neuritis associated with Q fever: case report and literature review. Int J Infect Dis. Sep 2010;14 Suppl 3:e269-73. [Medline].

  6. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Q Fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci. May 2009;1166:79-89. [Medline].

  7. Oyston PC, Davies C. Q fever: the neglected biothreat agent. J Med Microbiol. Jan 2011;60:9-21. [Medline].

  8. Marrie TJ, Stein A, Janigan D, Raoult D. Route of infection determines the clinical manifestations of acute Q fever. J Infect Dis. Feb 1996;173(2):484-7. [Medline].

  9. Marrie TJ. Q fever pneumonia. Infect Dis Clin North Am. Mar 2010;24(1):27-41. [Medline].

  10. Waag DM. Coxiella burnetii: host and bacterial responses to infection. Vaccine. Oct 16 2007;25(42):7288-95. [Medline].

  11. Cutler SJ, Bouzid M, Cutler RR. Q fever. J Infect. Apr 2007;54(4):313-8. [Medline].

  12. Hartzell JD, Wood-Morris RN, Martinez LJ, Trotta RF. Q fever: epidemiology, diagnosis, and treatment. Mayo Clin Proc. May 2008;83(5):574-9. [Medline].

  13. Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore). Mar 2000;79(2):109-23. [Medline].

  14. World Health Organization. Report of a WHO Group of Consultants. Health aspects of chemical and biological weapons. Geneva, Switzerland: WHO Press; 1970.

  15. Karakousis PC, Trucksis M, Dumler JS. Chronic Q fever in the United States. J Clin Microbiol. Jun 2006;44(6):2283-7. [Medline]. [Full Text].

  16. Centers for Disease Control and Prevention. Potential for Q fever infection among travelers returning from Iraq and the Netherlands. Available at http://emergency.cdc.gov/HAN/han00313.asp. Accessed May 12, 2010.

  17. Schimmer B, Morroy G, Dijkstra F, et al. Large ongoing Q fever outbreak in the south of The Netherlands, 2008. Euro Surveill. Jul 31 2008;13(31):[Medline]. [Full Text].

  18. Dupuis G, Petite J, Péter O, Vouilloz M. An important outbreak of human Q fever in a Swiss Alpine valley. Int J Epidemiol. Jun 1987;16(2):282-7. [Medline].

  19. Terheggen U, Leggat PA. Clinical manifestations of Q fever in adults and children. Travel Med Infect Dis. May 2007;5(3):159-64. [Medline].

  20. Scola BL. Current laboratory diagnosis of Q fever. Semin Pediatr Infect Dis. Oct 2002;13(4):257-62. [Medline].

  21. Raoult D, Houpikian P, Tissot Dupont H, et al. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med. Jan 25 1999;159(2):167-73. [Medline].

  22. Healy B, Llewelyn M, Westmoreland D, Lloyd G, Brown N. The value of follow-up after acute Q fever infection. J Infect. Apr 2006;52(4):e109-12. [Medline].

  23. Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents. Nov 2007;30 Suppl 1:S7-15. [Medline].

  24. Healy B, van Woerden H, Raoult D, et al. Chronic Q fever: different serological results in three countries--results of a follow-up study 6 years after a point source outbreak. Clin Infect Dis. Apr 15 2011;52(8):1013-9. [Medline].

  25. Brouillard JE, Terriff CM, Tofan A, Garrison MW. Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents. Pharmacotherapy. Jan 2006;26(1):3-14. [Medline].

  26. Moodie CE, Thompson HA, Meltzer MI, Swerdlow DL. Prophylaxis after exposure to Coxiella burnetii. Emerg Infect Dis. Oct 2008;14(10):1558-66. [Medline]. [Full Text].

  27. Parker NR, Barralet JH, Bell AM. Q fever. Lancet. Feb 25 2006;367(9511):679-88. [Medline].

  28. Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med. Mar 25 2002;162(6):701-4. [Medline].

Previous
Next
 
A: Chest radiograph with normal findings. B: Chest radiograph demonstrating Q fever pneumonia.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.